Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on a secondary analysis

Authors

Institutions

Publication Details

Journal
The Lancet Global Health
Published
2024-12-18
DOI
https://doi.org/10.1016/s2214-109x(24)00442-x
Citations
27
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
30.49
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on a secondary analysis

Rebekah Jane Moles, Lachlan Oldfield, Ardalan Mirzaei, Jonathan Penm
27 citations
The Lancet Global Health
Pharmaceutical Economics and Policy
30.49
article

Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on a secondary analysis

Rebekah Jane Moles, Lachlan Oldfield, Ardalan Mirzaei, Jonathan Penm
article en
27 citations

Abstract

No abstract available for this paper.
The Lancet Global HealthVol. 13(1)
The University of Sydney (AU)
No poverty
Openalex Percentile: Top 1%
Pharmaceutical Economics and Policy
30.49
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.